IDNA vs. ARKG ETF Comparison

Comparison of iShares Genomics Immunology and Healthcare ETF (IDNA) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
IDNA

iShares Genomics Immunology and Healthcare ETF

IDNA Description

The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.

Grade (RS Rating)

Last Trade

$46.37

Average Daily Volume

94,540

Number of Holdings *

45

* may have additional holdings in another (foreign) market
ARKG

ARK Genomic Revolution Multi-Sector ETF

ARKG Description Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.

Grade (RS Rating)

Last Trade

$90.34

Average Daily Volume

4,982,482

Number of Holdings *

47

* may have additional holdings in another (foreign) market
Performance
IDNA ARKG
30 Days -2.65% -2.12%
60 Days -12.54% -19.35%
90 Days -9.65% -16.32%
12 Months 61.85% 157.75%
13 Overlapping Holdings
Grade Symbol Weight in IDNA Weight in ARKG Overlap
F ARCT 0.55% 2.63% 0.55%
D CRSP 3.17% 3.53% 3.17%
F EDIT 1.92% 1.03% 1.03%
D FATE 5.02% 3.12% 3.12%
B NSTG 2.43% 0.85% 0.85%
C NTLA 2.76% 1.26% 1.26%
F NVTA 3.02% 2.82% 2.82%
F PSNL 0.43% 2.39% 0.43%
C REGN 3.89% 3.82% 3.82%
F SRPT 1.8% 1.35% 1.35%
F SYRS 0.21% 0.32% 0.21%
F TAK 3.69% 3.14% 3.14%
C TWST 3.48% 5.61% 3.48%
IDNA Overweight 32 Positions Relative to ARKG
Grade Symbol Weight
D BGNE 5.6%
B EXEL 4.92%
C GILD 4.27%
A BNTX 4.11%
C MRNA 3.73%
D BPMC 3.67%
F SGEN 3.22%
D LGND 1.87%
D SWTX 1.85%
F ALLO 1.76%
F VIR 1.61%
F BLUE 1.47%
C BCRX 1.41%
B MGNX 1.35%
B FPRX 1.34%
F FGEN 1.22%
F INO 1.14%
F SGMO 1.02%
F CNST 0.66%
F ADAP 0.54%
D ZIOP 0.53%
F VXRT 0.48%
F IBRX 0.47%
D TCRR 0.42%
C ISEE 0.36%
F AGEN 0.35%
F ALGS 0.33%
F ALT 0.32%
D DTIL 0.3%
D CTMX 0.27%
D RAPT 0.26%
F MTEM 0.24%
IDNA Underweight 34 Positions Relative to ARKG
Grade Symbol Weight
F TDOC -7.97%
D PACB -5.4%
D EXAS -3.98%
C CDNA -3.68%
C VRTX -3.44%
F IOVA -3.06%
D NVS -3.05%
C INCY -2.45%
F IONS -2.06%
C ACCD -1.94%
D PSTG -1.86%
B TXG -1.59%
D CSTL -1.58%
D BEAM -1.58%
F BLI -1.55%
B BMY -1.53%
C VEEV -1.53%
F CLLS -1.52%
D SDGR -1.5%
B TMO -1.47%
A GOOGL -1.37%
C CDXS -1.18%
D VCYT -1.13%
D PHR -1.02%
F ADPT -1.02%
B GH -1.0%
D AQB -0.79%
F MCRB -0.78%
F CERS -0.5%
C RPTX -0.39%
F SURF -0.36%
F LGVW.U -0.33%
D ONEM -0.13%
F ONVO -0.04%
Compare ETFs